PLXP

NASDAQ:PLXP

PLx Pharma Inc.

  • Stock

USD

Last Close

0.09

12/04 20:00

Market Cap

2.53M

Beta: 3.92

Volume Today

50.38M

Avg: 4.86M

PE Ratio

−0.13

PFCF: −0.06

    Description

    PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-infla...Show More

    Earnings

    Earnings per Share (Estimate*)

    -4-3-2-12014-05-122016-05-112018-03-232020-03-132022-03-11

    Revenue (Estimate*)

    1M2M3M4M5M6M7M2014-05-122016-05-112018-03-232020-03-132022-03-11

    *Estimate based on analyst consensus